The road to the first FDA-approved genetically engineered pig heart transplantation into human.
Autorzy:
Singh AK; University of Maryland School of Medicine, Baltimore, Maryland, USA. GriffithBP; University of Maryland School of Medicine, Baltimore, Maryland, USA. Goerlich CE; University of Maryland School of Medicine, Baltimore, Maryland, USA. Ayares D; Revivicor Inc, Blacksburg, Virginia, USA. Mohiuddin MM; University of Maryland School of Medicine, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
Xenotransplantation [Xenotransplantation] 2022 Sep; Vol. 29 (5), pp. e12776. Date of Electronic Publication: 2022 Sep 20.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Progressive genetic modifications of porcine cardiac xenografts extend survival to 9 months.
Autorzy:
Mohiuddin MM; Department of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA. Goerlich CE; Department of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA.; Department of Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. Singh AK; Department of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA. Zhang T; Department of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA. Tatarov I; Department of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA. Lewis B; Department of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA. Sentz F; Department of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA. Hershfeld A; Department of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA. Braileanu G; Department of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA. Odonkor P; Department of Anesthesiology, The University of Maryland School of Medicine, Baltimore, Maryland, USA. Strauss E; Department of Anesthesiology, The University of Maryland School of Medicine, Baltimore, Maryland, USA. Williams B; Department of Anesthesiology, The University of Maryland School of Medicine, Baltimore, Maryland, USA. Burke A; Department of Pathology, The University of Maryland School of Medicine, Baltimore, Maryland, USA. Hittman J; Department of Pathology, The University of Maryland School of Medicine, Baltimore, Maryland, USA. Bhutta A; Department of Pediatrics, The University of Maryland School of Medicine, Baltimore, Maryland, USA. Tabatabai A; Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA. Gupta A; Department of Medicine, Division of Cardiology, University of Maryland School of Medicine, Baltimore, Maryland, USA. Vaught T; Revivicor, Inc., Blacksburg, Virginia, USA. Sorrells L; Revivicor, Inc., Blacksburg, Virginia, USA. Kuravi K; Revivicor, Inc., Blacksburg, Virginia, USA. Dandro A; Revivicor, Inc., Blacksburg, Virginia, USA. Eyestone W; Revivicor, Inc., Blacksburg, Virginia, USA. Kaczorowski DJ; Department of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA. Ayares D; Revivicor, Inc., Blacksburg, Virginia, USA. GriffithBP; Department of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
Xenotransplantation [Xenotransplantation] 2022 May; Vol. 29 (3), pp. e12744. Date of Electronic Publication: 2022 Mar 31.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
